SML Genetree Co., Ltd of Seoul at MEDICA 2021 in Düsseldorf -- MEDICA - World Forum for Medicine
Manage stand orders
Select Option

SML Genetree Co., Ltd

6f, Baumoe-Ro 225, Seocho-Gu, 06740 Seoul
Korea, Republic
Telephone +82 2 20577900, +82 10 79135144
Fax +82 70 82303951
genetree@genetree.co.kr

Submit your contact details

Provide your contact details to the exhibitor. Optionally, you may also add a personal message.

Please log in

You must be logged in to send the contact request.

An error has occurred

Please check your internet connection or try again later.

Message has been sent

Your message to the exhibitor was sent successfully.

Hall map

MEDICA 2021 hall map (Hall 7a): stand B23

Fairground map

MEDICA 2021 fairground map: Hall 7a

Contact

Minzi Kwak

Korea, Republic

Phone
+82 10 7913 5144

Email
mzkwak@genetree.co.kr

David Seo

Korea, Republic

Phone
+82 10 3204 7708

Email
hdseo@genetree.co.kr

Please log in

You must be logged in to use matchmaking

Please log in for matchmaking

Registration is required to use the networking service and a separate registration for matchmaking. Please register for Matchmaking first.

Let's get started!

Welcome to Matchmaking. Would you like to get in touch with ?

Our range of products

Our products

Product category: Polymerase chain reaction (PCR)

Ezplex SARS-CoV-2 G Kit (FDA-EUA)

The Ezplex SARS-CoV-2 G Kit is a real-time PCR in vitro diagnostic test intended for the qualitative detection of nucleic acid from SARS-CoV-2 RdRp and N genes isolated and purified from nasopharyngeal and oropharyngeal swabs and sputum specimens obtained from individuals suspected of COVID-19 by their healthcare provider.
Testing can be quickly and accurately completed within 2 ½ hours post-extraction, and results produced using Genetree Viewer analysis software.

SML Genetree is one of the first Korean manufacturer obtained US FDA EUA with pooling protocol for Ezplex SARS-CoV-2 G Kit.

More Less

Product category: Polymerase chain reaction (PCR)

Ezplex® SARS-CoV2/RV FAST G Kit

The Ezplex® SARS-CoV2/RV FAST G Kit is a real-time PCR in vitro diagnostic test intended for the qualitative detection and differentiation of nucleic acids from the SARS-CoV-2 Virus (RdRp and N genes), Influenza A, Influenza B and Respiratory Syncytial Virus (RSV) from nasopharyngeal swabs obtained from individuals suspected of COVID-19 and/or respiratory infection. Testing can be quickly and accurately completed within approximately 35 minutes post-extraction and results produced using Genetree Viewer analysis software.

More Less

Product category: Polymerase chain reaction (PCR)

Ezplex™ MTBC NTM Real-time PCR Kit

The Ezplex™ MTBC/NTM Real-time PCR Kit is an in vitro diagnostic test intended for the simultaneous qualitative detection of Mycobacterium tuberculosis complex (MTBC) and 100 types of nontuberculous mycobacteria (NTM) DNA from sputum, bronchial fruid and culture from individuals suspected of MTBC and/or NTM.
Testing can be quickly and accurately completed within 2 hours post-extraction.

More Less

Product category: Polymerase chain reaction (PCR)

Ezplex® HPV NGS typing Kit

There are approximately 170 types of human papillomavirus (HPV). More than 40 are primarily transmitted through sexual contact.
High-risk HPV types are known to be closely related to genital cancer (cervical cancer). Some low-risk HPV types have been reported to be associated with genital warts and minor cell changes.
The Ezplex® HPV NGS Typing Kits are in vitro diagnostic tests intended to detect the genotype of human papillomavirus (HPV) using PCR and Next Generation Sequencing technology (NGS).
Tests are run on the Ion Chef/Ion Systems Genestudio S5 systems to dramatically reduce hands-on time, allowing analysis of 45 or 100 HPV genotypes.

More Less

Product category: Polymerase chain reaction (PCR)

Ezplex® Respiratory Pathogen Real-time PCR Kit

The Ezplex Respiratory Pathogen Real-time PCR Kit is an in vitro diagnostic test intended for the qualitative detection of nucleic acids from 19 types of respiratory viruses and 6 types of bacteria isolated and extracted from nasopharyngeal swabs.

More Less

Product category: Polymerase chain reaction (PCR)

Ezplex® SARS-CoV-2 FAST G Kit

The Ezplex SARS-CoV-2 FAST G Kit is a real-time PCR in vitro diagnostic test intended for the qualitative detection of nucleic acid from SARS-CoV-2 RdRp and N genes isolated and purified from upper respiratory (nasopharyngeal/oropharyngeal) swabs and lower respiratory (sputum) specimens obtained from individuals suspected of COVID-19.
Testing can be quickly and accurately completed within 35 minutes post-extraction and results produced using Genetree Viewer analysis software.

More Less

Product category: Polymerase chain reaction (PCR)

Ezplex® HP-CLA Real-time PCR Kit

The Ezplex® HP-CLA Real-time PCR Kit is an in vitro diagnostic test intended for the simultaneous qualitative detection and differentiation of Helicobacter pylori and clarithromycin resistant mutations from DNA extracted from human gastric tissue biopsies.
Testing can be quickly and accurately completed in less than 2 hours post-extraction and results produced using Genetree Viewer analysis software.

More Less

Company news

Date

Topic

20 Apr 2020

SML Genetree has obtained CE validation from the European Commission.

SEOUL, Korea, April 22, 2020 – SML Genetree has obtained CE-IVD (In Vitro Diagnostics) from the European Commission, allowing the use of SML Genetree’s Ezplex® SARS-CoV-2 G Kit in the EU markets. 

Medical devices in the EU undergo a conformity assessment, demonstrating legal requirements, and ensuring safety. A CE (Conformité Européenne) mark is received upon the passing of all standards. SML Genetree’s Ezplex® SARS-CoV-2 G Kit utilizes an innovative multiplex, real-time polymerase chain reaction (PCR), detecting 2 target genetics (RdRp, N). Automated analysis systems enable throughput at scale. 

SMLGenetree’s Ezplex® SARS-CoV-2 G Kit has proven to deliver 100% sensitivity and 100% specificity in tests administered by Korean and Japanese laboratories. Sensitivity is the ability of a test to correctly identify those with the disease (true positive rate), whereas test specificity is the ability of the test to correctly identify those without the disease (true negative rate). 

Original article: Korean Business News 
https://news.naver.com/main/read.nhn?mode=LSD&mid=sec&sid1=001&oid=215&aid=0000866061

More Less

About us

Company portrait

SML Genetree is a leading developer of multiplex molecular technologies and multiplex clinical molecular diagnostics based in South Korea.

SML Genetree is an affiliate of Samkwang Medical Laboratories (SML), one of the largest diagnostic commercial labs in South Korea since 1985.

Company data

Area of business Diagnostic tests

Company information as a PDF file